Literature DB >> 25320870

Organocatalytic diversity-oriented asymmetric synthesis of tricyclic chroman derivatives.

Zhi-Cong Geng1, Shao-Yun Zhang, Nai-Kai Li, Ning Li, Jian Chen, Hai-Yan Li, Xing-Wang Wang.   

Abstract

The tandem oxo-Michael-IED/HDA and oxo-Michael-IED/HDA-Michael-Aldol condensation transformations between (E)-2-hydroxyaryl-2-oxobut-3-enoate derivatives with enals have been developed in the presence of (S)-diphenylprolinol trimethylsilyl ether as an organocatalyst. Two types of tricyclic chroman derivatives were, respectively, obtained, by adjusting the reactant ratio and reaction temperature, in good yields (up to 96%) with excellent enantioselectivities (up to >99%) and good diastereoselectivities (up to >30/1). It should be noted that the divergent chiral chroman derivatives were obtained by successive reaction of (E)-2-hydroxyaryl-2-oxobut-3-enoate derivatives with two different enal substrates in highly catalytic results.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25320870     DOI: 10.1021/jo501560m

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Diastereodivergent Synthesis of Hexahydro-6H-benzo[c]chromen-6-one Derivatives Catalyzed by Modularly Designed Organocatalysts.

Authors:  Satish Jakkampudi; Ramarao Parella; Hadi D Arman; John C-G Zhao
Journal:  Chemistry       Date:  2019-05-09       Impact factor: 5.236

2.  Catalytic, Enantioselective, Intramolecular Sulfenofunctionalization of Alkenes with Phenols.

Authors:  Scott E Denmark; David J P Kornfilt
Journal:  J Org Chem       Date:  2017-03-03       Impact factor: 4.354

3.  Synthesis of Enantioenriched 3,4-Disubstituted Chromans through Lewis Base Catalyzed Carbosulfenylation.

Authors:  Travis Menard; Aragorn Laverny; Scott E Denmark
Journal:  J Org Chem       Date:  2021-10-21       Impact factor: 4.354

4.  Asymmetric synthesis of polysubstituted chiral chromans via an organocatalytic oxa-Michael-nitro-Michael domino reaction.

Authors:  Cheng-Ke Tang; Kai-Xiang Feng; Ai-Bao Xia; Chen Li; Ya-Yun Zheng; Zhen-Yuan Xu; Dan-Qian Xu
Journal:  RSC Adv       Date:  2018-01-17       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.